BRPI0517932A - muteìna humana de beta-interferon - Google Patents
muteìna humana de beta-interferonInfo
- Publication number
- BRPI0517932A BRPI0517932A BRPI0517932-7A BRPI0517932A BRPI0517932A BR PI0517932 A BRPI0517932 A BR PI0517932A BR PI0517932 A BRPI0517932 A BR PI0517932A BR PI0517932 A BRPI0517932 A BR PI0517932A
- Authority
- BR
- Brazil
- Prior art keywords
- interferon
- beta
- mutation
- human
- human beta
- Prior art date
Links
- 102000003996 Interferon-beta Human genes 0.000 title abstract 5
- 108090000467 Interferon-beta Proteins 0.000 title abstract 5
- 230000035772 mutation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2004-0088196 | 2004-11-02 | ||
KR1020040088196A KR100781666B1 (ko) | 2004-11-02 | 2004-11-02 | 인간 인터페론-베타 변이체 |
PCT/KR2005/003665 WO2006049423A1 (en) | 2004-11-02 | 2005-11-02 | Human interferon-beta mutein |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0517932A true BRPI0517932A (pt) | 2008-10-21 |
BRPI0517932A8 BRPI0517932A8 (pt) | 2018-05-02 |
BRPI0517932B1 BRPI0517932B1 (pt) | 2021-10-19 |
Family
ID=36319397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0517932-7A BRPI0517932B1 (pt) | 2004-11-02 | 2005-11-02 | Muteína humana de beta-interferon, polinucleotídeo, vetor de expressão, célula animal, método para preparação de referida muteína e composição farmacêutica compreedendo a mesma |
Country Status (11)
Country | Link |
---|---|
US (1) | US8101716B2 (pt) |
EP (1) | EP1809661B1 (pt) |
JP (1) | JP4637913B2 (pt) |
KR (1) | KR100781666B1 (pt) |
CN (1) | CN101111519B (pt) |
AT (1) | ATE509951T1 (pt) |
BR (1) | BRPI0517932B1 (pt) |
DK (1) | DK1809661T3 (pt) |
ES (1) | ES2369088T3 (pt) |
PT (1) | PT1809661E (pt) |
WO (1) | WO2006049423A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070085227A (ko) * | 2004-08-09 | 2007-08-27 | 앨리오스 바이오파마 인크. | 합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법 |
NZ580686A (en) | 2007-05-02 | 2012-11-30 | Ambrx Inc | Modified interferon beta polypeptides and their uses |
CN102260344A (zh) * | 2010-05-26 | 2011-11-30 | 重庆富进生物医药有限公司 | 缺失型人β干扰素及其重组制备 |
SG11201401071YA (en) * | 2011-10-01 | 2014-08-28 | Glytech Inc | Glycosylated polypeptide and pharmaceutical composition containing same |
MY171183A (en) | 2013-03-29 | 2019-09-30 | Glytech Inc | Polypeptide glycosylated with sialylated sugar chain |
ES2736503T3 (es) | 2014-04-04 | 2020-01-02 | Ares Trading Sa | Nuevos análogos de la proteína IFN beta |
WO2016013911A1 (ko) * | 2014-07-24 | 2016-01-28 | 에이비온 주식회사 | 페길화된 인터페론 -베타 변이체 |
WO2016013697A1 (ko) * | 2014-07-24 | 2016-01-28 | 에이비온 주식회사 | 인터페론-베타 변이체의 폴리에틸렌글리콜 배합체 |
US20210009720A1 (en) * | 2015-03-03 | 2021-01-14 | Genopharm Inc. | Human interferon-beta variant conjugated immunocytokine and method for preparing same |
KR101838919B1 (ko) * | 2015-03-03 | 2018-03-15 | 에이비온 주식회사 | 인간 인터페론-베타 변이체가 접합된 면역사이토카인 및 이의 제조방법 |
WO2016163764A2 (ko) * | 2015-04-07 | 2016-10-13 | 에이비온 주식회사 | 인터페론 베타 변이체의 안정화 제제 |
KR20180013587A (ko) | 2016-07-29 | 2018-02-07 | 서울대학교산학협력단 | cFLIP siRNA를 포함하는 인터페론 베타 저항성 암 질환 치료용 또는 감작용 조성물 |
KR101943160B1 (ko) * | 2016-10-06 | 2019-01-30 | 에이비온 주식회사 | 인터페론 베타 변이체의 안정화 제제 |
KR101955366B1 (ko) | 2017-06-02 | 2019-03-07 | 인제대학교 산학협력단 | 인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법 |
CN108117595B (zh) * | 2018-02-28 | 2020-06-26 | 中国科学院微生物研究所 | 一种犬α干扰素的制备及其应用 |
KR20210021861A (ko) * | 2019-08-19 | 2021-03-02 | (주)제노팜 | 사람 표피성장인자수용체 2 양성 암을 치료하기 위한 인터페론-베타 변이체 면역사이토카인의 용도 및 환자 선별 방법 |
CN115989239A (zh) * | 2020-04-29 | 2023-04-18 | 瑷备恩有限公司 | 具有双重突变的人干扰素β变体和用于改善人干扰素β变体的稳定性的方法 |
WO2021221470A1 (ko) * | 2020-04-29 | 2021-11-04 | (주) 제노팜 | 인터페론-베타 변이체와 항체가 융합된 재조합 단백질 및 이를 포함하는 약학 조성물 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4966843A (en) * | 1982-11-01 | 1990-10-30 | Cetus Corporation | Expression of interferon genes in Chinese hamster ovary cells |
DE4128319A1 (de) * | 1991-08-27 | 1993-03-04 | Bioferon Biochem Substanz | Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen |
DE19717864C2 (de) | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung |
US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
US6531122B1 (en) | 1999-08-27 | 2003-03-11 | Maxygen Aps | Interferon-β variants and conjugates |
CN1684979A (zh) * | 2002-08-31 | 2005-10-19 | 希杰株式会社 | 糖基化的人干扰素α同种型 |
AU2003277088A1 (en) * | 2002-10-01 | 2004-04-23 | Xencor, Inc | Interferon variants with improved properties |
KR100541850B1 (ko) * | 2003-03-31 | 2006-01-11 | 삼성정밀화학 주식회사 | 인간 인터페론-베타 변이체 및 그의 제조방법 |
-
2004
- 2004-11-02 KR KR1020040088196A patent/KR100781666B1/ko active IP Right Grant
-
2005
- 2005-11-02 CN CN2005800452915A patent/CN101111519B/zh active Active
- 2005-11-02 AT AT05804508T patent/ATE509951T1/de active
- 2005-11-02 WO PCT/KR2005/003665 patent/WO2006049423A1/en active Application Filing
- 2005-11-02 EP EP05804508A patent/EP1809661B1/en active Active
- 2005-11-02 JP JP2007540249A patent/JP4637913B2/ja active Active
- 2005-11-02 BR BRPI0517932-7A patent/BRPI0517932B1/pt active IP Right Grant
- 2005-11-02 PT PT05804508T patent/PT1809661E/pt unknown
- 2005-11-02 DK DK05804508.9T patent/DK1809661T3/da active
- 2005-11-02 US US11/718,449 patent/US8101716B2/en active Active
- 2005-11-02 ES ES05804508T patent/ES2369088T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP1809661B1 (en) | 2011-05-18 |
US20100003721A1 (en) | 2010-01-07 |
JP4637913B2 (ja) | 2011-02-23 |
EP1809661A4 (en) | 2008-02-06 |
US8101716B2 (en) | 2012-01-24 |
ES2369088T3 (es) | 2011-11-25 |
BRPI0517932B1 (pt) | 2021-10-19 |
CN101111519A (zh) | 2008-01-23 |
KR100781666B1 (ko) | 2007-12-03 |
ATE509951T1 (de) | 2011-06-15 |
KR20060039132A (ko) | 2006-05-08 |
DK1809661T3 (da) | 2011-09-05 |
BRPI0517932A8 (pt) | 2018-05-02 |
EP1809661A1 (en) | 2007-07-25 |
CN101111519B (zh) | 2012-11-07 |
JP2008518631A (ja) | 2008-06-05 |
PT1809661E (pt) | 2011-09-05 |
WO2006049423A1 (en) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0517932A (pt) | muteìna humana de beta-interferon | |
CY2018013I1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
NO20082473L (no) | Fremgangsmater, sammensetninger og sett for behandling av medisinske tilstander | |
DK1841332T3 (da) | Fortykningskomposition til dysfagi patienter | |
BRPI0507583A (pt) | adoçantes com baixo ìndice glicêmico e produtos feitos usando os mesmos | |
ATE525913T2 (de) | Fettzusammensetzungen | |
EP1919302B8 (en) | Food comprising silicon | |
DE602006018689D1 (de) | Inline Gefässversiegelungs- und trennungsinstrument | |
ATE394077T1 (de) | Prolaps-reparatur | |
DK1807083T3 (da) | Anvendelse af pirlindol til behandling af lidelser, der er kendetegnet ved proliferation af T-lymphocyter og/eller hyperproliferation af keratinocyter, især atopisk dermatitis og psoriasis | |
BRPI0517799A (pt) | composição para facilitar o parto humano | |
DK1948561T3 (da) | Multi-substitueret hydroxyapatit og sammensætning deraf med en naturlig og/eller syntetisk polymer, fremstilling og anvendelser deraf | |
NO20075702L (no) | Polymersjikt med lav fuktighet i ikke-autoklav fremgangsmate | |
DK1765859T3 (da) | Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf | |
DE602005025158D1 (de) | Zuckerrohrpflanze mit erhöhtem speicherkohlenhydratgehalt | |
DK2094992T3 (da) | Ledkæde | |
EA200701820A1 (ru) | Применение диосметиновых соединений при лечении и профилактике тромботических патологий | |
DK1976548T3 (da) | VIP-fragmenter og sammensætninger deraf | |
UY29236A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización. | |
DK1858481T3 (da) | Ophthalmologiske sammensætninger og anvendelse deraf | |
CY1110891T1 (el) | Παραγωγα 6-ετεροαρυλπυριδοϊνδολονης, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη | |
ATE450576T1 (de) | Transparente polyamidzusammensetzungen und damit hergestellte artikel | |
ECSP077423A (es) | Coadministración de tigeciclina y digoxin | |
ITMI20062222A1 (it) | Macchina per l'arrotondamento particolarmente di pezzi di pasta di pane e simili. | |
ATE449332T1 (de) | Alterungsbiomarker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: REFERENCEBIOLABS CO., LTD. (KR) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B25A | Requested transfer of rights approved |
Owner name: ABION INC. (KR) |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: DESPACHO: PARA QUE A PETICAO NO 870190036018 DE 15/04/2019 POSSA SER ACATADA COMO RECURSOAO ARQUIVAMENTO, O DEPOSITANTE DEVERA REALIZAR O PAGAMENTO DO VALOR DA RETRIBUICAO DEVIDA. |
|
B12C | Appeal against dismissal [chapter 12.3 patent gazette] | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] | ||
B11N | Dismissal: publication cancelled [chapter 11.14 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 11.20 NA RPI NO 2594 DE 24/09/2020 POR TER SIDO INDEVIDA. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/11/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |